and the data science communities.
Discover how researchers are using NIH/NCI genomics and proteomics data to gain insight into chemotherapy resistance in triple negative breast cancer.
An NCI training grant and resources such as the NCI Cancer Research Data Commons’ Genomic Data Commons, in part, made it possible for this study to use multimodal deep learning. This model allowed researchers to examine pathology whole slide images and molecular profile data from 14 cancer types to enable more accurate patient outcome predictions.
NCI’s Imaging Data Commons has released several notable updates, including the release of three collections by the Human Tumor Atlas Network, which comprise a new multichannel fluorescence imaging data set.
Celebrate the NCI team that recently received a 2022 FedHealthIT Innovation Award for their commitment to advancing cancer research through work proteomics efforts such as the Proteomic Data Commons.
If you’re attending the 2022 American Association for Cancer Research Annual Meeting (either in person or virtual), don’t miss these data science sessions, poster presentations, and the NCI exhibit booth, where you can hear more about our programs and activities!